[Federal Register: April 13, 1999 (Volume 64, Number 70)]
[Notices]               
[Page 18037]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr13ap99-95]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

 
National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 109(d) of the Federal Advisory Committee Act, 
as amended (5 U.S.C. Appendix 2), notice is hereby given of the 
following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.
    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel Adult Therapeutic Clinical Trials 
Program for AIDS--Statistical & Data Management Center.
    Date: May 11-14, 1999.
    Time: May 11, 1999, 7:00 PM to recess.
    Agenda: To review and evaluate grant applications.
    Place: Holiday Inn Georgetown, Kaleidoscope Room, 2101 Wisconsin 
Avenue, Washington, DC 20007.
    Time: May 12, 1999, 9:00 AM to adjournment.
    Agenda: To review and evaluate grant applications.
    Place: Holiday Inn Georgetown, Kaleidoscope Room, 2101 Wisconsin 
Avenue, Washington, DC 20007.
    Contact Person: Peter R. Jackson, Scientific Review Administrator, 
Scientific Review Program, Division of Extramural Activities, NIAID, 
NIH, Solar Building, Room 4C10, 6003 Executive Boulevard MSC 7610, 
Bethesda, MD 20892-7610, 301-496-8426.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: April 6, 1999.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy, NIH.
[FR Doc. 99-9101 Filed 4-12-99; 8:45 am]
BILLING CODE 4140-01-M